Trial reportScientific reports2026
Effect of breathing exercises on depression, sexual function, and exercise capacity in postmenopausal women: a randomized controlled trial.
Trial report in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This trial aimed to explore the effect of supervised breathing exercises (BEs) on depression, sexual function, and exercise capacity in postmenopausal women. Sixty-four depressed postmenopausal women with associated sexual dysfunction were equally assigned to either a BEs group, which received diaphragmatic BEs, or a non-exercising control group. Both groups received individualized antidepressants and vaginal lubricants. Depressive symptoms were assessed using the Beck Depression Inventory-II (BDI-II), sexual function using the Female Sexual Function Index (FSFI), and exercise capacity using the six-minute walk test (6MWT) at baseline and after 12 weeks. At the end of the study, the BEs group showed significantly greater reductions in BDI-II scores (mean difference = − 4.22; 95% CI, − 6.19 to − 2.24; p = 0.001) and significantly greater increases in FSFI scores (mean difference = 5.01; 95% CI, 3.21 to 6.79; p = 0.001) compared with the control group with clinically significant differences for both measures. However, the between-group difference in 6MWT distance was not significant (mean difference = 28.28 m; 95% CI, − 2 to 58.57; p = 0.06). BEs could be an effective therapeutic intervention for managing depression and sexual dysfunction in this population of postmenopausal women, while no significant effect was observed on exercise capacity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.